|
49
|
163
|
3dpfA |
Crystal structure of the complex between mmp-8 and a non-zinc chelating inhibitor |
|
49
|
163
|
3dngA |
Crystal structure of the complex between mmp-8 and a non-zinc chelating inhibitor |
|
62
|
237
|
3dl1A |
Crystal structure of a putative metal-dependent hydrolase (yp_001336084.1) from klebsiella pneumoniae subsp. pneumoniae mgh 78578 at 2.20 a resolution |
|
47
|
163
|
3dpeA |
Crystal structure of the complex between mmp-8 and a non-zinc chelating inhibitor |
|
82
|
256
|
3ckiA |
Crystal structure of the tace-n-timp-3 complex |
|
56
|
365
|
3ba0A |
Crystal structure of full-length human mmp-12 |
|
84
|
293
|
3b2zA |
Crystal structure of adamts4 (apo form) |
|
71
|
217
|
3b8zA |
High resolution crystal structure of the catalytic domain of adamts-5 (aggrecanase-2) |
|
32
|
157
|
3aykA |
Catalytic fragment of human fibroblast collagenase complexed with cgs-27023a, nmr, minimized average structure |
|
83
|
259
|
3b92A |
Novel thio-based tace inhibitors part 2: rational design, synthesis and sar of thiol-contaning aryl sufones |
|
46
|
166
|
3ayuA |
Crystal structure of mmp-2 active site mutant in complex with app-drived decapeptide inhibitor |
|
70
|
201
|
3aigA |
Adamalysin ii with peptidomimetic inhibitor pol656 |
|
25
|
158
|
2z2dA |
Solution structure of human macrophage elastase (mmp-12) catalytic domain complexed with a gamma-keto butanoic acid inhibitor |
|
46
|
169
|
2yigA |
Mmp13 in complex with a novel selective non zinc binding inhibitor |
|
29
|
142
|
2yufA |
Solution structure of the ncd2 domain in human transcriptional repressor nab1 protein |
|
270
|
696
|
2yb9A |
Crystal structure of human neutral endopeptidase complexed with a heteroarylalanine diacid. |
|
48
|
165
|
2y6cA |
The discovery of mmp7 inhibitors exploiting a novel selectivity trigger |
|
54
|
166
|
2xs3A |
Structure of karilysin catalytic mmp domain |
|
48
|
166
|
2y6dA |
The discovery of mmp7 inhibitors exploiting a novel selectivity trigger |
|
50
|
167
|
2xs4A |
Structure of karilysin catalytic mmp domain in complex with magnesium |
|
57
|
180
|
2x7mA |
Crystal structure of archaemetzincin (amza) from methanopyrus kandleri at 1.5 a resolution |
|
88
|
318
|
2x3bA |
Asap1 inactive mutant e294a, an extracellular toxic zinc metalloendopeptidase |
|
93
|
318
|
2x3aA |
Asap1 inactive mutant e294q, an extracellular toxic zinc metalloendopeptidase |
|
47
|
163
|
2wo8A |
Mmp12 complex with a beta hydroxy carboxylic acid |
|
86
|
319
|
2x3cA |
Asap1 inactive mutant e294q, an extracellular toxic zinc metalloendopeptidase |
|
47
|
162
|
2wo9A |
Mmp12 complex with a beta hydroxy carboxylic acid |
|
49
|
163
|
2woaA |
Mmp12 complex with a beta hydroxy carboxylic acid |
|
77
|
202
|
2w12A |
High-resolution crystal structure of the p-i snake venom metalloproteinase bap1 in complex with a peptidomimetic: insights into inhibitor binding |
|
78
|
202
|
2w15A |
High-resolution crystal structure of the p-i snake venom metalloproteinase bap1 in complex with a peptidomimetic: insights into inhibitor binding |
|
81
|
202
|
2w13A |
High-resolution crystal structure of the p-i snake venom metalloproteinase bap1 in complex with a peptidomimetic: insights into inhibitor binding |
|
47
|
158
|
2w0dA |
Does a fast nuclear magnetic resonance spectroscopy- and x-ray crystallography hybrid approach provide reliable structural information of ligand-protein complexes? a case study of metalloproteinases. |
|
78
|
202
|
2w14A |
High-resolution crystal structure of the p-i snake venom metalloproteinase bap1 in complex with a peptidomimetic: insights into inhibitor binding |
|
93
|
296
|
2v4bA |
Crystal structure of human adamts-1 catalytic domain and cysteine- rich domain (apo-form) |
|
84
|
295
|
2rjpA |
Crystal structure of adamts4 with inhibitor bound |
|
84
|
292
|
2rjqA |
Crystal structure of adamts5 with inhibitor bound |
|
47
|
163
|
2tclA |
Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor |
|
48
|
165
|
2usnA |
Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with thiadiazole inhibitor pnu-141803 |
|
29
|
173
|
2srtA |
Catalytic domain of human stromelysin-1 at ph 5.5 and 40oc complexed with inhibitor |
|
276
|
696
|
2qpjA |
Human nep complexed with a bifunctional nep/dpp iv inhibitor |
|
45
|
165
|
2pjtA |
Crystal structure of the catalytic domain of mmp-13 complexed with way-344 |
|
43
|
158
|
2oxzA |
Human mmp-12 in complex with two peptides pqg and iag |
|
44
|
158
|
2oxwA |
Human mmp-12 complexed with the peptide iag |
|
42
|
167
|
2ow9A |
Crystal structure analysis of the mmp13 catalytic domain in complex with specific inhibitor |
|
28
|
164
|
2pojA |
Nmr solution structure of the inhibitor-free state of macrophage metalloelastase (mmp-12) |
|
41
|
159
|
2ow0A |
Mmp-9 active site mutant with iodine-labeled carboxylate inhibitor |
|
89
|
266
|
2oi0A |
Crystal structure analysis 0f the tnf-a coverting enzyme (tace) in complexed with aryl-sulfonamide |
|
266
|
654
|
2o36A |
Crystal structure of engineered thimet oligopeptidase with neurolysin specificity in neurotensin cleavage site |
|
47
|
157
|
2oy4A |
Uninhibited human mmp-8 |
|
44
|
159
|
2ow1A |
Mmp-9 active site mutant with trifluoromethyl hydroxamate inhibitor |
|
43
|
158
|
2oxuA |
Uninhibited form of human mmp-12 |
